Skip to content

Neuropace, Inc. NPCE Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$6.69M-1.5%-$2.73M+48.0%-$3.5M+35.9%-$8.65M-15.1%-$6.59M+26.2%
$60K+22.4%$80K+66.7%$100K0.0%$100K0.0%$49K+8.9%
$2.28M-13.3%$2.61M+0.2%$2.63M+1.4%$3.23M+26.7%$2.63M+3.4%
-$5.9M+21.1%$0+100%-$1.94M-12.8%-$2.09M+46.5%-$7.48M+0.6%
$117K+216%$97K+149%$30K-70.0%$168K+167%$37K-64.4%
-$117K-216%-$97K-105%-$30K-102%-$168K-105%-$37K-102%
$0-100%$49.55M
-$166K-101%$635K-25.1%$21.11M+29,217%
-$6.18M-146%$1.04M+153%$13.59M+369%
-$6.02M+20.0%$0+100%-$1.97M-8.2%-$2.25M+43.1%-$7.52M+1.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Neuropace, Inc. generate?
Neuropace, Inc. (NPCE) generated -$9.9M in operating cash flow over the trailing twelve months.
What is Neuropace, Inc.'s free cash flow?
After $412.0K of capital expenditures, Neuropace, Inc.'s free cash flow was -$10.2M over the trailing twelve months, up 43.5% year over year.
Where does Neuropace, Inc.'s cash flow data come from?
Every line is extracted from Neuropace, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.